GR-1 / RC-14 and Vaginal Flora (also called microbiota) In one of the randomized clinical trials, 75% of women in the GR-1 / RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement. Fem-Dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri. RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
- New Shelf Stable
- No Refrigeration Necessary
- Vaginal/Urinary Tract Health
- Suitable for Vegetarians/Vegans
- Oral Probiotic Supplement
